Evaluation of the sensitivity of commercially available digoxin radioimmunoassay kits. 1976

N P Kubasik, and J L Hall, and S S Barold, and M T Volosin, and H E Sine

We have evaluated the technical minimum detection limits of 12 different commercially available kits and the practical minimum detection limits of 11 kits used for the determination of the serum digoxin level by radioimmunoassay. The poor technical ability of many of the kits to distinguish between digoxin levels of 0.1 ng/ml intervals between 0 and 0.5 ng/ml and, additionally, the detection of a digoxin level up to 0.3 ng/ml with some of the kits in glycoside-free sera impose a practical working minimum detection limit of 0.5 ng/ml for the majority of these kits. We, therefore, recommend caution with interpreting or evaluating serum digoxin levels below 0.5 ng/ml.

UI MeSH Term Description Entries
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013677 Medical Laboratory Science The specialty related to the performance of techniques in clinical pathology such as those in hematology, microbiology, and other general clinical laboratory applications. Medical Laboratory Technology,Technology, Medical Laboratory,Clinical Laboratory Science,Clinical Laboratory Sciences,Laboratory Science, Clinical,Laboratory Science, Medical,Laboratory Sciences, Clinical,Laboratory Sciences, Medical,Laboratory Technologies, Medical,Laboratory Technology, Medical,Medical Laboratory Sciences,Medical Laboratory Technologies,Science, Clinical Laboratory,Science, Medical Laboratory,Sciences, Clinical Laboratory,Sciences, Medical Laboratory,Technologies, Medical Laboratory

Related Publications

N P Kubasik, and J L Hall, and S S Barold, and M T Volosin, and H E Sine
December 1975, The American journal of cardiology,
N P Kubasik, and J L Hall, and S S Barold, and M T Volosin, and H E Sine
January 1978, Clinical chemistry,
N P Kubasik, and J L Hall, and S S Barold, and M T Volosin, and H E Sine
May 1979, Clinical chemistry,
N P Kubasik, and J L Hall, and S S Barold, and M T Volosin, and H E Sine
July 1981, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie,
N P Kubasik, and J L Hall, and S S Barold, and M T Volosin, and H E Sine
October 1978, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie,
N P Kubasik, and J L Hall, and S S Barold, and M T Volosin, and H E Sine
September 1982, Annals of clinical biochemistry,
N P Kubasik, and J L Hall, and S S Barold, and M T Volosin, and H E Sine
July 1975, Clinical chemistry,
N P Kubasik, and J L Hall, and S S Barold, and M T Volosin, and H E Sine
October 1989, Clinical chemistry,
N P Kubasik, and J L Hall, and S S Barold, and M T Volosin, and H E Sine
April 1981, The Journal of infectious diseases,
N P Kubasik, and J L Hall, and S S Barold, and M T Volosin, and H E Sine
January 2003, British journal of biomedical science,
Copied contents to your clipboard!